FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4–GSK3β–Nrf2 signaling

Yong Teng, Huakan Zhao, Lixia Gao, Wenfa Zhang, Austin Y. Shull, Chloe Shay

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The tumor microenvironment induces endoplasmic reticulum (ER) stress in tumor cells, an event that can promote progression, but it is unknown how tumor cells adapt to this stress. In this study, we show that the fibroblast growth factor FGF19, a gene frequently amplified in hepatocellular carcinoma (HCC), facilitates a survival response to ER stress. Levels of FGF19 expression were increased in stressed HCC cells in culture and in a mouse xenograft model. Induction of ER stress required the transcription factor ATF4, which directly bound the FGF19 promoter. In cells where ER stress was induced, FGF19 overexpression promoted HCC cell survival and increased resistance to apoptosis, whereas FGF19 silencing counteracted these effects. Mechanistic investigations implicated glycogen synthase kinase-3b (GSK3b) in regulating nuclear accumulation of the stress-regulated transcription factor Nrf2 activated by FGF19. Our findings show how FGF19 provides a cytoprotective role against ER stress by activating a FGFR4–GSK3b–Nrf2 signaling cascade, with implications for targeting this signaling node as a candidate therapeutic regimen for HCC management.

Original languageEnglish (US)
Pages (from-to)6215-6225
Number of pages11
JournalCancer Research
Volume77
Issue number22
DOIs
StatePublished - Nov 15 2017

Fingerprint

Endoplasmic Reticulum Stress
Hepatocellular Carcinoma
Activating Transcription Factor 4
Glycogen Synthase Kinases
Tumor Microenvironment
Fibroblast Growth Factors
Heterografts
Neoplasms
Cell Survival
Transcription Factors
Cell Culture Techniques
Apoptosis
Genes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4–GSK3β–Nrf2 signaling. / Teng, Yong; Zhao, Huakan; Gao, Lixia; Zhang, Wenfa; Shull, Austin Y.; Shay, Chloe.

In: Cancer Research, Vol. 77, No. 22, 15.11.2017, p. 6215-6225.

Research output: Contribution to journalArticle

Teng, Yong ; Zhao, Huakan ; Gao, Lixia ; Zhang, Wenfa ; Shull, Austin Y. ; Shay, Chloe. / FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4–GSK3β–Nrf2 signaling. In: Cancer Research. 2017 ; Vol. 77, No. 22. pp. 6215-6225.
@article{2c5cc0dc76a047ea8ddf3c563cf98e95,
title = "FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4–GSK3β–Nrf2 signaling",
abstract = "The tumor microenvironment induces endoplasmic reticulum (ER) stress in tumor cells, an event that can promote progression, but it is unknown how tumor cells adapt to this stress. In this study, we show that the fibroblast growth factor FGF19, a gene frequently amplified in hepatocellular carcinoma (HCC), facilitates a survival response to ER stress. Levels of FGF19 expression were increased in stressed HCC cells in culture and in a mouse xenograft model. Induction of ER stress required the transcription factor ATF4, which directly bound the FGF19 promoter. In cells where ER stress was induced, FGF19 overexpression promoted HCC cell survival and increased resistance to apoptosis, whereas FGF19 silencing counteracted these effects. Mechanistic investigations implicated glycogen synthase kinase-3b (GSK3b) in regulating nuclear accumulation of the stress-regulated transcription factor Nrf2 activated by FGF19. Our findings show how FGF19 provides a cytoprotective role against ER stress by activating a FGFR4–GSK3b–Nrf2 signaling cascade, with implications for targeting this signaling node as a candidate therapeutic regimen for HCC management.",
author = "Yong Teng and Huakan Zhao and Lixia Gao and Wenfa Zhang and Shull, {Austin Y.} and Chloe Shay",
year = "2017",
month = "11",
day = "15",
doi = "10.1158/0008-5472.CAN-17-2039",
language = "English (US)",
volume = "77",
pages = "6215--6225",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4–GSK3β–Nrf2 signaling

AU - Teng, Yong

AU - Zhao, Huakan

AU - Gao, Lixia

AU - Zhang, Wenfa

AU - Shull, Austin Y.

AU - Shay, Chloe

PY - 2017/11/15

Y1 - 2017/11/15

N2 - The tumor microenvironment induces endoplasmic reticulum (ER) stress in tumor cells, an event that can promote progression, but it is unknown how tumor cells adapt to this stress. In this study, we show that the fibroblast growth factor FGF19, a gene frequently amplified in hepatocellular carcinoma (HCC), facilitates a survival response to ER stress. Levels of FGF19 expression were increased in stressed HCC cells in culture and in a mouse xenograft model. Induction of ER stress required the transcription factor ATF4, which directly bound the FGF19 promoter. In cells where ER stress was induced, FGF19 overexpression promoted HCC cell survival and increased resistance to apoptosis, whereas FGF19 silencing counteracted these effects. Mechanistic investigations implicated glycogen synthase kinase-3b (GSK3b) in regulating nuclear accumulation of the stress-regulated transcription factor Nrf2 activated by FGF19. Our findings show how FGF19 provides a cytoprotective role against ER stress by activating a FGFR4–GSK3b–Nrf2 signaling cascade, with implications for targeting this signaling node as a candidate therapeutic regimen for HCC management.

AB - The tumor microenvironment induces endoplasmic reticulum (ER) stress in tumor cells, an event that can promote progression, but it is unknown how tumor cells adapt to this stress. In this study, we show that the fibroblast growth factor FGF19, a gene frequently amplified in hepatocellular carcinoma (HCC), facilitates a survival response to ER stress. Levels of FGF19 expression were increased in stressed HCC cells in culture and in a mouse xenograft model. Induction of ER stress required the transcription factor ATF4, which directly bound the FGF19 promoter. In cells where ER stress was induced, FGF19 overexpression promoted HCC cell survival and increased resistance to apoptosis, whereas FGF19 silencing counteracted these effects. Mechanistic investigations implicated glycogen synthase kinase-3b (GSK3b) in regulating nuclear accumulation of the stress-regulated transcription factor Nrf2 activated by FGF19. Our findings show how FGF19 provides a cytoprotective role against ER stress by activating a FGFR4–GSK3b–Nrf2 signaling cascade, with implications for targeting this signaling node as a candidate therapeutic regimen for HCC management.

UR - http://www.scopus.com/inward/record.url?scp=85033794905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033794905&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-17-2039

DO - 10.1158/0008-5472.CAN-17-2039

M3 - Article

VL - 77

SP - 6215

EP - 6225

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 22

ER -